• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Radiofrequency ablation for treatment of Barrett's esophagus: A systematic review and cost analysis
2009     HAYES, Inc. VasoView HemoPro endoscopic vein harvesting system (Maquet Cardiovascular LLC) for coronary artery bypass graft (CABG)
2009     National Institute for Health and Care Excellence (NICE) Implantation of an opaque intraocular lens for intractable double vision. NICE interventional procedures guidance 293
2009     HAYES, Inc. Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2009     National Institute for Health and Care Excellence (NICE) Extracorporeal photopheresis for Crohn's disease. NICE interventional procedures guidance 288
2009     HAYES, Inc. Botulinum toxin treatment for essential tremor and spasticity for indications other than cerebral palsy and stroke
2009     National Institute for Health and Care Excellence (NICE) Intraocular lens insertion for correction of refractive error, with preservation of the natural lens. NICE interventional procedures guidance 289
2009     HAYES, Inc. High-Dose immunosuppressive therapy with or without hematopoietic transplantation for the treatment of rheumatic and mixed autoimmune diseases
2009     National Institute for Health and Care Excellence (NICE) Laparoscopic cystectomy. NICE interventional procedures guidance 287
2009     HAYES, Inc. Lung transplantation
2009     National Institute for Health and Care Excellence (NICE) Functional electrical stimulation for drop foot of central neurological origin. NICE interventional procedures guidance 278
2009     HAYES, Inc. Positron Emission Tomography (PET) for monitoring and prognosis of lung cancer
2009     National Institute for Health and Care Excellence (NICE) Ultrasound-guided regional nerve block. NICE interventional procedures guidance 285
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Extracorporeal liver support of liver failure by means of Prometheus system]
2009     HAYES, Inc. Postoperative disposable ambulatory regional anesthesia
2009     Andalusian Health Technology Assessment Area (AETSA) [Helical tomotherapy. Current uses and utility]
2009     National Institute for Health and Care Excellence (NICE) Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation. NICE interventional procedures guidance 286
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting Beta2-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation
2009     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Post-introduction observation of health technologies. A methodological guideline
2009     HAYES, Inc. Trigger point injections for myofascial pain
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment for thoracic aorta lesions]
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Identification, prioritisation and assessment of obsolete health technologies. A methodological guideline
2009     HAYES, Inc. Uterine artery embolization
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Strategies for the diffusion and dissemination of health technology assessment (HTA) products
2009     HAYES, Inc. Vagus nerve stimulation for depression
2009     HAYES, Inc. Vagus nerve stimulation for epilepsy
2009     NIHR Health Technology Assessment programme Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
2009     NIHR Health Technology Assessment programme Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice
2009     HAYES, Inc. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C)
2009     NIHR Health Technology Assessment programme How far does screening women for partner violence in different health care settings meet the UK National Screening Committee criteria for a screening programme in terms of condition, screening method and intervention?
2009     NIHR Health Technology Assessment programme Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY) - a pharmacoepidemiological and qualitative study
2009     NIHR Health Technology Assessment programme Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
2009     HAYES, Inc. Ancillary urinary cytokeratin (CK) tests for bladder cancer screening and detection
2009     HAYES, Inc. BRCA1 and BRCA2 sequence variant analysis for susceptibility to hereditary ovarian cancer
2009     Health Council of the Netherlands Gezondheidsraad (GR) Proton radiotherapy
2009     HAYES, Inc. Ancillary urinary microsatellite analysis (MA) for bladder cancer screening and detection
2009     HAYES, Inc. ColoSure colorectal cancer detection test
2009     Health Council of the Netherlands Gezondheidsraad (GR) [The hospital as a healing environment]
2009     HAYES, Inc. deCODE ProstateCancer (deCODE diagnostics)
2009     Health Council of the Netherlands Gezondheidsraad (GR) Autism spectrum disorders: A lifetime of difference
2009     Technology Assessment at SickKids (TASK) Systematic review on orchidopexy for the Canadian Paediatric Surgical Wait Times project
2009     NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: systematic review of clinical and cost effectiveness, and natural history
2009     NIHR Health Technology Assessment programme Funding to cover the costs incurred to hold the 4th International Balliol Surgical Trials Colloquia
2009     HAYES, Inc. Late-onset familial alzheimer disease (AD2)
2009     Health Council of the Netherlands Gezondheidsraad (GR) General vaccination against hepatitis B revisited
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2009     HAYES, Inc. Maturity-Onset Diabetes of the Young (MODY)
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Pregnancy immunisation by red blood cells]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009     HAYES, Inc. MYH-Associated Polyposis (MAP)
2009     Health Council of the Netherlands Gezondheidsraad (GR) Care for the unborn child
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2009     HAYES, Inc. PathFinderTG test for pancreatic cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pyxis and medDISPENSE automated medication dispensing systems: a review of the clinical benefits and harms, cost-effectiveness, and guidelines for use
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oxybutynin, tolterodine, and darifenacin: review of cognitive adverse events
2009     NIHR Health Technology Assessment programme Telbivudine for the treatment of chronic hepatitis B infection
2009     Health Council of the Netherlands Gezondheidsraad (GR) A national colorectal cancer screening programme
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared to fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: supplementary analyses relating to risk of infection from an unknown virus
2009     NIHR Health Technology Assessment programme Entecavir for the treatment of chronic hepatitis B infection
2009     Belgian Health Care Knowledge Centre (KCE) Tiotropium in the treatment of chronic obstructive pulmonary disease health technology assessment
2009     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pandemic influenza A/H1N1 2009: target groups and prioritisation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) n-3 lipids for patients on total parenteral nutrition: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cetuximab (Erbitux) in EGFR-expressing Non-Small Cell Lung Cancer
2009     Belgian Health Care Knowledge Centre (KCE) Positron Emission Tomography (PET) in Belgium: an update
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Prevention in the elderly: Focus on functioning in daily life]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
2009     NIHR Health Technology Assessment programme Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus (Afinitor) for advanced/metastatic kidney cancer
2009     Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and non-pharmaceutical interventions for Alzheimer's Disease, a rapid assessment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009     NIHR Health Technology Assessment programme Ustekinumab for the treatment of moderate to severe psoriasis
2009     Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and nonpharmaceutical interventions for Alzheimer’s disease, a rapid assessment
2009     Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
2009     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamins and minerals
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
2009     Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
2009     Belgian Health Care Knowledge Centre (KCE) Endobronchial valves in the treatment of severe pulmonary emphysema: a rapid health technology assessment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009     Belgian Health Care Knowledge Centre (KCE) Use of point-of-care devices in patients with oral anticoagulation : a Health Technology Assessment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009     Belgian Health Care Knowledge Centre (KCE) Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: rapid assessment
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Telemedicine in Stroke Management. Systematic Review
2009     HAYES, Inc. Chromoendoscopy for colonoscopy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography for pediatric patients: review of clinical effectiveness and indications for use
2009     University of York Cognitive behaviour therapy for schizophrenia
2009     Belgian Health Care Knowledge Centre (KCE) Robot-assisted surgery: health technology assessment
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Systematic review of the multidisciplinary combined treatment in peritoneal neoplasms. Radical surgical citoreduction + intraperitoneal chemotherapy +/- hyperthermia (Sugarbaker's technique)
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009     University of York Physical health monitoring for people with schizophrenia or other serious mental illness
2009     Penn Medicine Center for Evidence-based Practice (CEP) Hybrid revascularization
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins: review of the comparative effectiveness for various indications
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes